The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 14, 2023
Filed:
Aug. 08, 2014
Applicant:
Novan, Inc., Durham, NC (US);
Inventors:
Ryan Doxey, Raleigh, NC (US);
Jian Bao, Cary, NC (US);
Assignee:
Novan, Inc., Durham, NC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 33/00 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01); A61K 9/06 (2006.01); A61K 47/52 (2017.01); A61K 47/59 (2017.01); A61K 8/04 (2006.01); A61K 8/25 (2006.01); A61K 8/34 (2006.01); A61K 8/898 (2006.01); A61K 9/10 (2006.01); A61K 9/107 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61K 47/44 (2017.01); A61Q 17/00 (2006.01); A61Q 19/00 (2006.01);
U.S. Cl.
CPC ...
A61K 33/00 (2013.01); A61K 8/042 (2013.01); A61K 8/25 (2013.01); A61K 8/345 (2013.01); A61K 8/898 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/10 (2013.01); A61K 9/107 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01); A61K 47/44 (2013.01); A61K 47/52 (2017.08); A61K 47/59 (2017.08); A61Q 17/005 (2013.01); A61Q 19/00 (2013.01); A61K 2800/22 (2013.01);
Abstract
The present invention generally relates to topical compositions and methods of using the same. A preferred topical pharmaceutical composition comprises a nitric oxide-releasing active pharmaceutical ingredient in admixture with a hydrophilic composition and a hydrophobic composition wherein the nitric oxide-releasing active pharmaceutical ingredient comprises a nitric oxide-releasing compound having a diazeniumdiolate functional group.